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Edited by Irmgard SinningAbstract Two nrdF genes of Mycobacterium tuberculosis code
for diﬀerent R2 subunits of the class Ib ribonucleotide reductase
(RNR). The proteins are denoted R2F-1 and R2F-2 having 71%
sequence identity. The R2F-2 subunit forms the biologically
active RNR complex with the catalytic R1E-subunit. We present
the structure of the reduced R2F-2 subunit to 2.2 A resolution.
Comparison of the R2F-2 structure with a model of R2F-1
suggests that the important diﬀerences are located at the C-
terminus. We found that within class Ib, the E-helix close to the
iron diiron centre has two preferred conformations, which cannot
be explained by the redox-state of the diiron centre. In the R2F-2
structure, we also could see a mobility of aE in between the two
conformations.
 2004 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Ribonucleotide reductase catalyses the reduction of all four
ribonucleotides to their corresponding deoxyribonucleotides
and therefore plays a central role in DNA biosynthesis and
nucleotide metabolism. Three distinctly diﬀerent classes of ri-
bonucleotide reductase (RNR) have been described [1–4],
which share the common feature of the radical-based catalytic
mechanism [5,6]. Several organisms have been found to code
for two or even three classes of RNR [7,8].
All mammalian RNRs, as well as that from aerobically
grown Escherichia coli, and DNA viruses belong to class I and
use non-heme binuclear iron cofactors for generation of the
essential tyrosyl radicals [9,10]. Class I enzymes have further
been divided into Ia and Ib after the discovery of a new type of
RNR with a new pattern of allosteric activity regulation [7].
The class Ia enzymes have two diﬀerent allosteric binding sites,
one site where binding of ATP activates and dATP inhibits
nucleotide reduction (the on/oﬀ switch) and one binding site* Corresponding author. Fax: +46-18-536971.
E-mail address: ulla.uhlin@molbio.slu.se (U. Uhlin).
Abbreviations: RNR, ribonucleotide reductase; Mtb, Mycobacterium
tuberculosis; EPR, electron paramagnetic resonance
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doi:10.1016/j.febslet.2004.05.059for substrate speciﬁcity [11,12]. The on/oﬀ switch is missing in
class Ib [7,13].
All class I enzymes are composed of two homodimeric
proteins, R1 and R2. To distinguish between subclass Ia and
Ib the proteins of class Ib RNRs are named R1E and R2F
after their encoding genes nrdE and nrdF, respectively [14].
Binding sites for substrates (NDPs) and allosteric eﬀectors
(ATP, dNTPs) are localised in the large R1 subunit [15]. The
small R2 subunit contains a tyrosyl free radical that is pro-
duced by a neighbouring diiron site. Since the discovery of the
stable tyrosyl radical [16] in RNR from E. coli (class Ia), this
enzyme has been extensively studied. Based on structural and
biochemical studies, a long-range coupled electron/proton
transfer over 35 A [17–20] and a substrate–radical catalytic
mechanism [21] have been established.
The class Ib RNRs have been found in widely diﬀerent
prokaryotes, including Salmonella typhimurium, Lactococcus
lactis, Bacillus subtilis, Mycoplasma genitalium, and Myco-
bacterium tuberculosis (Mtb), as well as in aerobically grown
E. coli [14,22–25]. In the cases known, class Ib RNRs are
normally not expressed in vivo, with the only exception so far
being Mtb RNR. The RNR enzyme from this pathogen has
attracted attention because tuberculosis remains a major glo-
bal disease infecting one-third of the world population and
killing more than 2 million people each year [26]. The resis-
tance against known drugs is becoming an increasing problem
and since RNR is a potential drug target it is important to
investigate the features of this particular enzyme.
The class Ib R1E homo-dimer from Mtb has a predicted
molecular mass of 2 83 kDa. Surprisingly, two separate
genes, nrdF1 and nrdF2, encode for the small RNR protein.
They are denoted R2F-1 and R2F-2 and have 71% amino acid
identity [27]. The calculated molar masses of R2F-1 and R2F-2
are 2 36.6 kDa (322 amino acids per monomer) and 2 37.0
kDa (324 amino acids per monomer), respectively. Both are
postulated to contain an iron-radical site like other class I R2
proteins [27]. Enzymatic investigations revealed that R2F-2
forms the recombinant active enzyme together with R1E. Also
R2F-1 was able to form a holo-complex with R1E in vivo, but
only if it was present in concentrations higher than the R2F-2.
It was suggested that there might be a second R1E to com-
plement R2F-1 or that an active complex with the known R1E
forms when R2F-1 is present in high enough concentrations.
The C-terminus of the small subunit is shown to be essential
for binding to the large subunit for formation of the holo-
complex [28–30]. This binding is species speciﬁc and can thus
be used for constructing drugs to prevent the formation ofblished by Elsevier B.V. All rights reserved.
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the R2 C-terminus on R1 has been identiﬁed in E. coli [19] but
no structure of any RNR class I holo-complex has yet been
published. Of the class I RNRs, crystal structures of R1 and
R2 subunits from E. coli and R1E and R2F from S. ty-
phimurium have been solved, as well as the R2 protein from
mouse, the R2/R4 protein from S. cerevisiae and R2F from C.
ammoniagenes [4].
Here, we present the structure of the class Ib small subunit
R2F-2 from Mtb with the diiron site in its reduced state. The
structure shows a similar fold to the previously solved struc-
tures of class Ib R2F subunits from S. typhimurium [31] and C.
ammoniagenes [32].2. Materials and methods
2.1. Overexpression and puriﬁcation
The overexpression and puriﬁcation of the R2F-2 protein from Mtb
was performed as described earlier [27].
2.2. Crystallisation
The protein was crystallised using the hanging drop vapour diﬀusion
method. Initial crystals were obtained in Hampton Screen II, tube no.
14 diluted 1:1 with distilled water. The drops with the reﬁned crys-
tallisation condition contained a 1:1 mix of protein solution (22 mg/ml
R2F-2 in 50 mM Tris, pH 7.5, 0.1 mM DTT) and reservoir solution
consisting of 0.6 M ammonium sulfate, 100 mM sodium citrate buﬀer,
pH 5.6, and 50 mM Na/K tartrate. Crystals in the shape of rhombo-
hedral plates started growing at 15 C after 1 day and increased in size
for approximately 1 week.
2.3. Data collection and reﬁnement
Crystals were cryo protected using reservoir solution supplemented
with 30% glycerol and immediately ﬂash-cooled in liquid nitrogen.
Diﬀraction data were collected at the European Synchrotron Radi-
ation Facility (ESRF), beamline ID29, Grenoble, France. The HKL
software suite programs [33] were used for data processing and scaling.
For initial phasing, molecular replacement was performed in the
program Molrep (ccp4) [34,35] using the R2F structure of S. ty-Table 1
Data collection and reﬁnement statistics
Beamline ESRF, ID29
Wavelength (A) 0.9756
Cell parameters (A, ) 161, 161, 116, 90, 90, 90
Space group p42212
Resolution range (A) 40–2.2 (2.24–2.20)
Redundancy 4.84
Rmergea 9.1 (44.4)
I=r (I) 10.0 (1.7)
Completeness (%) 99.0 (93.5)
No. observations 373,499
No. unique reﬂections 77,125
Rcrystb 0.18
Rfreec 0.20
No. non-hydrogen atoms 7359
No. solvent molecules 391
r.m.s.d. bond length (A) 0.023
r.m.s.d. angle () 1.85
Average B-factor (A2) 28.4









i IiðhklÞÞ  100% for n
independent reﬂections and i observations of a given reﬂection.
hIðhklÞi is the average intensity of the I observation.
bRcryst ¼
P
h kFoðhÞj  jFcðhÞk=
P
h jFoðhÞj, where Fo and Fc are the
observed and calculated structure factors, respectively.
cRfree is equivalent to Fcryst for a 5% subset of reﬂections not used in the
reﬁnement.phimurium RNR as search model. This structure was also used to
create a model of Mtb R2F-2 with the program Swiss Model [36]. The
resulting model became the starting structure for rebuilding. After ri-
gid body reﬁnement and subsequent maximum likelihood reﬁnement
(Refmac5, ccp4 suite) [37], water picking was performed with wARP
(ccp4) [38].
The crystals belong to the tetragonal spacegroup P42212 and the cell
parameters are a ¼ b ¼ 161 A, c ¼ 116 A. There are three subunits in
the asymmetric unit, one dimer and one single monomer making up for
a solvent content of 63%. A threefold NCS constraint was used in the
beginning of the reﬁnement to ease model building, but as the reﬁne-
ment proceeded diﬀerences between the molecules arose and the re-
straint was removed.
The free R-value was calculated from 5% of the data and monitored
throughout the reﬁnement. Interpretation of maps and model building
were performed using the program O [39]. Stereochemical quality was
evaluated with Procheck [40] and analysis of the agreement between
the atomic model and X-ray data was performed with Sfcheck [41] and
EDS [42]. Data and reﬁnement statistics are summarised in Table 1.
Initial coordinates, topology and parameter ﬁles for the small mol-
ecules found in the structure (citrate and glycerol) were taken from the
HIC-UP ligand database [43].3. Results and discussion
3.1. Overall structure
The R2F-2 from Mtb is an all helical protein and has a
similar fold to the former known R2 structures [18,31,32,44].
As expected, it is most similar to the structures of S. ty-
phimurium R2F (rmsd 1.04 A for 283Ca) and C. ammoniagenes
R2F (rmsd 0.86 A for 285Ca). These class Ib RNRs have a
sequence identity of 77% and 66%, respectively, to Mtb R2F-2.
One R2F-2 monomer is made up of 11 helices of which
eight, aA-H, form a bundle. Three shorter helices, a1, a2 and
a4, are peripherally located in the structure (Fig. 1). There are
three monomers in the asymmetric unit, one dimer and one
monomer creating a dimer interaction through a crystallo-
graphic twofold axis. The shape of the R2 dimer from E. coli
has been compared to a heart where each monomer forms one
lobe and two b-strands form the tip of the heart. The two b-
strands are missing in all other solved R2 structures including
the Mtb R2F-2.
The electron density is well deﬁned for all three subunits. Of
the 324 amino acids in the R2F-2 sequence, 288 have been
traced in the electron density for the best deﬁned subunit. The
ﬁrst 8–9 residues are not visible as well as the last 28–38 resi-
dues, with variations between the molecules in the asymmetricFig. 1. Structure of Mycobacterium tuberculosis R2F-2 dimer. The
subunits are coloured in beige and red, respectively, and the irons in
the metal centre are shown as yellow spheres. Figs. 1, 2 and 4 were
prepared using PyMOL [55].
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a0, is not present in Mtb R2F-2.
The unstructured C-terminus seems to be a common feature
of all R2 structures and it is thought to facilitate the interac-
tion with the larger subunit. Studies performed with NMR
have shown that the C-terminal peptide of R2 becomes
structured upon binding to R1 [45,46] and several enzymatic
experiments show that the C-terminus of R2 is an eﬀective
inhibitor for complex formation between R1 and R2 [27–
29,47,48].
During the reﬁnement it became apparent from the electron
density maps that amino acid residue 146 probably is a serine
and not a tyrosine as sequenced. There is not enough room for
the side chain of a tyrosine (Fig. 2).
3.2. The metal site
The crystals were not treated with any reducing agent prior
to data collection and were probably in their oxidised state
when subjected to X-ray radiation. However, the coordination
of the irons in Mtb R2F-2 is characteristic for a reduced iron
centre (Fig. 3(a) and (b)).
The two irons in R2F-2 are ligated by two histidines
(His106, His200), one aspartate (Asp72), three glutamates
(Glu103, Glu163, Glu197) and one water molecule. Glutamate
103 and 197 are both bridging the two irons, and Glu163 li-
gates bidentate to Fe2. The water molecule binds only to Fe2
making it six-coordinate with a square-pyramidal shape as
opposed to Fe1, which has four ligands creating a tetrahedral
coordination. This coordination is identical in the structure of
the reduced S. typhimurium R2F, while in the reduced C.
ammoniagenes R2F, the water molecule ligating Fe2 is absent.
In the structure of the reduced E. coli R2, there is no water
coordinating any of the irons and the glutamate correspondingFig. 2. The helices D, E (left) and G (right) in R2F-2. During the
structure reﬁnement, it became apparent from the electron density
maps that residue 146 in the C-terminal part of aD is a serine and not a
tyrosine as earlier sequenced. The serine makes a clear hydrogen bond
to the carbonyl oxygen of residue 154 in the N-terminal part of aE.
The ﬁnal 2Fo–Fc map is contoured at 1r and the tyrosine side chain is
shown in khaki.to Glu163 ligates monodentate to Fe2, not bidentate as in the
class Ib enzymes. Where both the ferrous and the ferric states
of the iron site have been studied from the same class Ib R2F,
this glutamate changes its conformation between the states.
The glutamate moves from bidentate binding of the Fe2 in the
ferrous state to monodentate binding in the ferric state. By this
move, space is formed for one of the bridging glutamates,
which then in the oxidised state loses the ligand to Fe1 and
only ligates Fe2 (Fig. 3(b) and (c)).
The intermetal distances in R2F-2 from Mtb are between 3.5
and 3.7 A varying slightly among the diﬀerent molecules in the
asymmetric unit. The corresponding distances in the reduced
C. ammoniagenes and S. typhimurium R2F structures are 3.9
and 3.7 A, respectively. In the reduced E. coli R2 structure, the
iron–iron distance is 3.9 A.
The predominantly seen reduced iron centre is thought to be
an eﬀect of reduction in the X-ray beam. Glu197 in Mtb is not
perfectly deﬁned in the electron density maps, suggesting a
non-uniform conformation possibly indicating slightly diﬀer-
ent oxidation states between the molecules in the crystal. A
similar reducing eﬀect was observed in the S. typhimurium and
C. ammoniagenes structures [31,32] as well as in thawed and
refrozen R2 protein from E. coli [49]. Reduction by X-ray
radiation has also been reported for other diiron enzymes [50].
Several datasets were collected, but all of them were found
to be reduced. Combination of initial images from diﬀerent
crystals shows only minor diﬀerences compared to full data-
sets. When the structure of R2F from S. typhimurium was
solved, it was discovered that the use of glycerol as a cryo
protectant promoted reduction of the diiron centre, and to
capture the oxidised state PEG400 was used. In the case of
Mtb R2F-2, however, the metal centre was found to be re-
duced with either glycerol or PEG400 as cryo protectant.
A theoretical model of the oxidised iron centre in R2F-2
from Mtb was made based on the S. typhimurium structure
[51]. The arrangement of the carboxylate ligands in the model
of the oxidised Mtb protein is identical to the one seen in the
X-ray structure of R2F-2 with a reduced metal centre. Ac-
cording to the theoretical model, the only diﬀerences between
the two states might be the ligation of water molecules and the
presumed l-oxo bridge in the oxidised state. If this model is
correct, assuming only minor diﬀerences between the states, it
might be diﬃcult to distinguish the oxidised from the reduced
state.
3.3. The tyrosyl radical
The radical forming tyrosine in Mtb R2F-2, Tyr110, is about
6.8 A from the closest iron atom. The corresponding distances
in C. ammoniagenes and S. typhimurium are 7 and 6.5–7 A,
respectively. In E. coli R2, the position of the tyrosine re-
sponsible for storing the radical diﬀers from the position in the
class Ib proteins. Tyr122 in E. coli R2 is situated about 5 A
from Fe1, whereas in the class Ib structures solved so far this
distance is longer and bridged by a water molecule. The more
distant tyrosine and the bridging water molecule have been
suggested to be common features among the class Ib proteins
[32]. The long iron-radical distance in Mtb has previously been
indicated by EPR measurements. It was found that saturation
of the tyrosyl radical occurs at lower applied microwave power
than that of the tyrosyl radicals in E. coli and mouse [51,52]
reﬂecting a much weaker magnetic interaction between the
radical and the iron centre and thus also a longer distance
Fig. 3. Comparison of reduced and oxidised diiron centres. (a) Schematic picture of the reduced diiron site in Mtb R2F-2. (b) Crystallographic
structure of the reduced diiron site in R2F-2 from Mtb. The iron coordination is identical to the one in the reduced S. typhimurium R2F (numbering
in parenthesis). Final Fo–Fc map is contoured at 3r where the iron ligating Glu197 was excluded from the calculation. (c) Structure of the oxidised
diiron centre in S. typhimurium. (a) was made using MDLISIS/Draw. (b) and (c) were made using Swiss-Pdb Viewer [56] (oﬃcial URL, http://
expasy.org/spdbv) and rendered with POV-Ray (oﬃcial URL, http://www.povray.org).
120 M. Uppsten et al. / FEBS Letters 569 (2004) 117–122between them. This is consistent with the structural diﬀerences
described above.
The iron centre in Mtb R2F-2 was studied at high EPR
microwave frequency at 4 K reporting a high g1, indicating a
predominantly non-hydrogen bonded tyrosyl radical
[53,51,54]. In the crystal structure of the reduced R2F-2 from
Mtb, Tyr110 is in its protonated state and within hydrogen
bonding distance (2.8 A) of a water molecule, which in turn
forms a hydrogen bond to Asp72. The distance between the
phenolic oxygen of Tyr110 and the closest carboxylate oxygen
of Asp72 is 4.5–4.8 A. The radical site in the R2F protein from
S. typhimurium has similar features in its reduced state, with a
water molecule forming a bridge between the tyrosine and the
iron-ligating aspartate. When the structure of S. typhimurium
R2F was solved with an oxidised radical site, however, the
presence of the water molecule could not be assured, leaving
the tyrosine without hydrogen bonds closer than 4 A away
from the aspartate. Crystallographic investigations of C. am-
moniagenes show that the water molecule is present in both
oxidation states, hydrogen bonding to the tyrosine residue.
EPR measurements have further characterised the structure
of the tyrosyl radical in Mtb R2F-2, indicating the b-methy-
lene protons of the tyrosine side chain to be situated with di-
hedral angles of about 50 (h1) and 70 (h2) with respect to the
pz orbital of the aromatic ring [51]. These values diﬀer some-
what from the ones observed in the X-ray structure, where h1
varies between 38 and 43, and h2 between 77 and 82 in the
three molecules in the asymmetric unit.
The tyrosine residue involved in radical storage in RNR is in
all known structures located in a hydrophobic pocket close to
the metal centre. By EPR studies, the tyrosine in Mtb R2F-2 isshown to have the same locked conformation at all tempera-
tures, suggesting a rigid environment [51]. This unusual sta-
bility is, however, not possible to explain by structural
comparisons to other R2 proteins.
3.4. The aE helix
The aE is one of the helices in the four-helix bundle pro-
viding ligands to the metal centre. In all solved R2 structures,
the hydrogen-bonding pattern of the aE helix is distorted. This
is due to an extra amino acid causing the formation of a p-type
turn in the middle of the helix.
The distortion diﬀers among earlier determined R2 struc-
tures [31,32,44,49] and there seems to be a tendency for two
conformations of aE among the class Ib structures (Fig. 4).
One of the preferred conformations (conf 1) is seen in the
structure of Mtb R2F-2, where the diiron centre is reduced. It
has the same conformation as aE in S. typhimurium when the
diiron centre is oxidised (rmsd 0.24 for 29 Ca atoms in aE). In
the structure of S. typhimurium where the irons are reduced,
however, the conformation of aE (conf 2) is very similar to the
one seen in the structures of C. ammoniagenes regardless of the
redox-state of the metal centre.
Variations between the conformations are most distinct in
one helix turn between two conserved phenylalanines (Phe167
and Phe171 in Mtb) and the most pronounced movement is
displayed by a tyrosine residue (Tyr168 in Mtb, Tyr163 in S.
typhimurium). The position of the tyrosine diﬀers by about 2.5
A between the two conformations. In Mtb R2F-2, conf 1, the
tyrosine stretches out to the surface of the protein and in the
oxidised structure of S. typhimurium the corresponding Tyr163
forms a hydrogen bond to residue 288 stabilising a few addi-
Fig. 4. Stereo cartoon showing conformational diﬀerences in helix E.
Comparison of the Mtb R2F-2 monomer with the R2F monomer from
S. typhimurium, both with reduced Fe-centre. The Mtb R2F-2 mono-
mer is coloured in pink and its helix E in red, whereas R2F from S.
typhimurium is shown in light blue and its helix E in darker blue. The
two monomers have very similar folds except in the helix E region
where the most pronounced movement is displayed by a tyrosine
(Y168 in Mtb, Y163 in S. typhimurium). The tyrosine residue stretches
out to the surface of the protein in the Mtb structure. The two iron
ions are shown as yellow spheres.
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hydrogen bond, however, can not be observed in the Mtb
structure.
Diﬀerences seen between the two preferred conformations
are very similar to those observed between the reduced wt E.
coli R2 and a mutant where Ser211 was mutated to an alanine
[49]. With the exception of R2F from S. typhimurium, there is
no correlation between alternate conformations of aE and the
redox-state of the diiron centre in wild type R2 proteins of
either class Ia or Ib.
In the Mtb R2F-2 structure, there are indications of move-
ments in the aE helix. Diﬀerence Fourier maps (Fo-Fc) reveal
that aE has more than one conformation, indicating mobility
from conf 1 towards conf 2. The movement of aE, however,
can not be associated with a certain redox-state of the metal
centre and the mobility of the helix has not been possible to
explain by data currently available. However, there is a pos-
sibility that it could be an eﬀect of radiation.
3.5. R2F-1
A three-dimensional molecular model for Mtb protein R2F-
1 was built based on the structure of Mtb R2F-2. The proteins
are homologous, having a 71% identity on the amino acid le-
vel. All the iron ligands and mechanism-related residues are
conserved in both proteins as well as the residues postulated to
be involved in the hydrogen bonded pathway for the radical.
The hydrophobic pocket where the tyrosyl radical is stored is
almost identical in the two proteins. The only diﬀerence is
Met189 in R2F-2, which is a leucine in R2F-1. This hydro-
phobic residue is located about 7 A from the radical storing
tyrosine and is by this exchange unlikely to aﬀect the stability
of the radical. The R2F from S. typhimurium also has a leucine
at this position, while in C. ammoniagenes there is an
isoleucine.
A comparison of the aE region in the R2F-2 structure and
the R2F-1 model reveals very similar structures. The biggest
diﬀerence is a phenylalanine in R2F-2 (Phe258), which is atyrosine in R2F-1. This residue is positioned on aH, adjacent
to aE, in the gate where the most prominent movement of aE
takes place. A tyrosine at this position could enable stabilisa-
tion of the aE helix by the formation of a hydrogen bond
between the hydroxyl group of the tyrosine and the carbonyl
oxygen of residue 168 (R2F-2 numbering) in aE. In all R2F
subunits known so far, this residue is a phenylalanine except
for R2F-1 from Mtb where it is a tyrosine. Also, the class Ia
R2 proteins, E. coli and mouse, have tyrosines at this position
but the hydrogen bond suggested above cannot be observed in
the X-ray structures of these proteins.
The structural similarity between R2F-1 and R2F-2 indi-
cates that both should be functional for radical transfer. So,
why does not R2F-1 function together with R1E? The answer
can probably be found in the diﬀerences in amino acid com-
position of the C-terminus of the two R2Fs. Inhibition studies
with C-terminal peptides illustrate that the R1E protein has a
much higher aﬃnity for the C-terminus of R2F-2 than that of
R2F-1 [27]. These results, in combination with enzymatic
studies, demonstrate that R2F-2 is more likely to be the
complementing subunit to R1E, able to form an active
holo-complex. The true function of R2F-1 requires further
elucidation.
The coordinates and structure factors have been deposited at
the PDB databank: code 1uzr (coordinates) and code r1uzrsf
(structure factors).
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